Goldman Sachs Future Health Care Equity ETF Rating $33.15 +0.14 (+0.42%) Closing price 10/15/2025 04:10 PM EasternExtended Trading$33.14 -0.01 (-0.02%) As of 08:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Goldman Sachs Future Health Care Equity ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GDOC Aggregate RatingModerate Buy 2.76Holdings in GDOC have an aggregate rating of Moderate Buy based on 402 analyst ratings issued in the past year covering 19 companies (72.0% of the portfolio).GDOC Aggregate Price Target$33.15High Prediction$33.15Average Prediction$33.15Low Prediction$33.15Holdings in GDOC have an aggregate price target of $33.15 and a range of $33.15 to $33.15 covering 19 companies (72.0% of the portfolio).GDOC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Goldman Sachs Future Health Care Equity ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 19 GDOC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings10.18%LLYEli Lilly and Company$826.20+1.7%4.9964 of 5 stars2.68$948.06 14.7%25Trending NewsAnalyst UpgradeAnalyst Revision7.76%BSXBoston Scientific$97.77+1.6%4.8767 of 5 stars3.00$120.71 23.5%27Positive NewsUpcoming Earnings6.37%ABTAbbott Laboratories$129.35-2.9%4.971 of 5 stars2.91$146.17 13.0%22Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionGap DownHigh Trading Volume6.02%ABBVAbbVie$226.31-1.2%4.6426 of 5 stars2.71$231.90 2.5%28Trending NewsAnalyst ForecastOptions VolumeAnalyst Revision4.40%ISRGIntuitive Surgical$435.61-0.2%4.9362 of 5 stars2.57$582.14 33.6%23Trending NewsUpcoming EarningsAnalyst ForecastAnalyst Revision4.34%PODDInsulet$312.45-1.8%4.7775 of 5 stars2.91$348.05 11.4%22Trending NewsAnalyst ForecastAnalyst Revision3.96%TMOThermo Fisher Scientific$527.34+0.3%4.9179 of 5 stars2.71$589.10 11.7%21Trending NewsUpcoming EarningsAnalyst ForecastAnalyst Revision3.45%AAgilent Technologies$139.14+0.8%4.0897 of 5 stars2.67$149.62 7.5%15Analyst ForecastAnalyst Revision3.30%ALNYAlnylam Pharmaceuticals$470.27+0.2%4.0181 of 5 stars2.82$457.08 -2.8%28Trending NewsAnalyst ForecastAnalyst Revision3.24%ARGXargenex$815.61+0.3%3.6293 of 5 stars3.00$817.53 0.2%24Trending NewsAnalyst ForecastAnalyst Revision3.01%CORCencora$320.02+0.7%4.2525 of 5 stars2.75$324.91 1.5%12Positive NewsAnalyst Forecast2.72%VEEVVeeva Systems$287.40-0.1%4.0819 of 5 stars2.56$307.58 7.0%252.67%NBIXNeurocrine Biosciences$137.73+0.4%4.825 of 5 stars2.80$163.44 18.7%20Positive News2.64%BMRNBioMarin Pharmaceutical$53.09+1.2%4.9271 of 5 stars2.55$93.26 75.7%22Analyst Revision1.86%MTDMettler-Toledo International$1,304.18+0.1%4.0111 of 5 stars2.42$1,336.50 2.5%12Positive News1.80%DHRDanaher$206.32+0.1%4.9753 of 5 stars2.74$244.60 18.6%23Positive NewsUpcoming EarningsAnalyst Revision1.54%IRTCiRhythm Technologies$175.67-0.7%1.4907 of 5 stars2.80$184.85 5.2%15Analyst Forecast1.35%ROIVRoivant Sciences$16.99+3.6%3.0723 of 5 stars2.80$19.94 17.3%10Insider Trade1.35%UNHUnitedHealth Group$360.77+0.2%4.8206 of 5 stars2.46$384.09 6.5%28Positive NewsAnalyst Forecast This page (NYSEARCA:GDOC) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A Millionaire With SEVEN Clicks? $1,000 in just seven stocks in 2004 could have turned into a million-dolla...The Oxford Club | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredA Major Economic Change Is Happening NowLouis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Goldman Sachs Future Health Care Equity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Goldman Sachs Future Health Care Equity ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
